News

11/23/2020

TKL Research Sold to QuintilesIMS (NYSE:Q)

TKL Research’s clinical trials division is a full-service, global dermatology specialty clinical research organization (CRO), serving the pharmaceutical, biotechnology, and consumer healthcare industries.